Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios

• Hiroyuki Suzuki,
• Shota Kise,
• Yuta Kaizuka,
• Reo Watanabe,
• Tsubasa Sugawa,
• Takako Furukawa,
• Hirofumi Fujii,
• Tomoya Uehara

Affiliations

Hiroyuki Suzuki

Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan

Shota Kise

Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan

Yuta Kaizuka

Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan

Reo Watanabe

Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan

Tsubasa Sugawa

Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan

Takako Furukawa

Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

Hirofumi Fujii

Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan

Tomoya Uehara

Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan